2018 Volume 44 - Canada Communicable Disease Report (CCDR)

ISSN: 1481-8531

2018 Volume 44

CCDR: Volume 44-12, December 6, 2018: Adult immunization

• Investigation and management of a large community mumps outbreak among young adults in Toronto, Canada, January 2017–February 2018
• Outbreak of invasive Streptococcus pneumoniae among an inner-city population in Victoria, British Columbia, 2016–2017
• HIV in Canada—Surveillance Report, 2017
• Vaccine safety surveillance in Canada: reports to CAEFISS, 2017
• Evidence for optimal HIV screening and testing intervals in HIV-negative individuals from various risk groups: A systematic review
• What is new in the Canadian Immunization Guide: November 2016 to November 2018
• Correction for Can Commun Dis Rep 2018;44(11)
• Authors’ Correction: Can Commun Dis Rep 2018;44(9)
• Thank you to all the peer reviewers for CCDR in 2018

CCDR: Volume 44-11, November 1, 2018: Healthcare-associated infections and antimicrobial resistance

• Something wicked this way comes: What health care providers need to know about Candida auris
• Bringing home unwelcome souvenirs: Travel and drug‑resistant bacteria
• National Advisory Committee on Infection Prevention and Control in Canada: A new name for a longstanding group
• Tuberculosis drug resistance in Canada: 2017
• Surveillance of laboratory exposures to human pathogens and toxins: Canada 2017
• CPHLN recommendations for the laboratory detection of Shiga toxin-producing Escherichia coli (O157 and non‑O157)
• Can Commun Dis Rep 2018;44(10)

CCDR: Volume 44-10, October 4, 2018: Climate change and Lyme diseases

• The continued rise of Lyme disease in Ontario, Canada: 2017
• Ixodes scapularis tick distribution and infection rates in Ottawa, Ontario, 2017
• A scoping review of Lyme disease research relevant for public health
• A scoping review of Lyme disease research relevant for public health – Supplementary References
• Results of a population screening intervention for tuberculosis in a Nunavik village, Quebec, 2015–2016
• Outbreak of Salmonella Chailey infections linked to precut coconut pieces — United States and Canada, 2017
• Advancing knowledge and increasing capacity to address climate-driven infectious diseases in Canada
• Correction for Can Commun Dis Rep Supplement 2018;44(9)

CCDR: Volume 44-9, September 6, 2018: Respiratory infections

• Clinical characteristics of pediatric pertussis cases, Quebec 2015–2017
• Should equivocal Bordetella pertussis PCR results in children be reported to public health?
• Influenza outbreaks in Ontario hospitals, 2012–2016
• Vaccine safety surveillance in Canada: Reports to CAEFISS, 2013–2016
• Rat bite fever on Vancouver Island: 2010–2016
• Summary of the NACI Update on Herpes Zoster Vaccines
• Updated NACI recommendations for measles post-exposure Prophylaxis

CCDR: Volume 44-7/8, July 5, 2018: Can we eliminate hepatitis C?

• Impact of availability of direct-acting antivirals for hepatitis C on Canadian hospitalization rates, 2012–2016
• Awareness and knowledge of hepatitis C among health care providers and the public: A scoping review
• Barriers to and facilitators of hepatitis C virus screening and testing: A scoping review
• Hepatitis C virus infection in Saskatchewan First Nations communities: Challenges and innovations
• A summary of the Pan-Canadian framework on sexually-transmitted and blood-borne infections
• Community outbreak of invasive group A streptococcus infection in Ontario, Canada
• Hep C in Canada 2018: infographic

CCDR: Volume 44-6, June 7, 2018: Vacine update

• Summary of the NACI Seasonal Influenza Vaccine Statement for 2018–2019 
• Summary of the NACI literature review on the comparative effectiveness of subunit and split virus inactivated influenza vaccines in older adults 
• Do health care providers trust product monograph information regarding use of vaccines in pregnancy? A qualitative study
• Pre-clinical development of a vaccine against Lassa fever 
• Strategies for increasing uptake of vaccination in pregnancy in high-income countries: A systematic review
• Biological feasibility and importance of a gonorrhea vaccine for global public health
• First imported case of Mayaro virus detected in Canada

CCDR: Volume 44-5, May 3, 2018: Emergency Response

• Fifteen years post-SARS: Key milestones in Canada's public health emergency response
• An overview of the National Microbiology Laboratory emergency management program
• Canadian Pandemic Influenza Preparedness: Communications strategy
• Misidentification of Risk Group 3/Security Sensitive Biological Agents by MALDI-TOF MS in Canada: November 2015–October 2017
• Raccoon rabies outbreak in Hamilton, Ontario: A progress report
• CATMAT: Use of booster doses of yellow fever vaccine
• Update on CATMAT's evidence-based recommendations

CCDR: Volume 44-3/4, March 1, 2018: Can we eliminate Tuberculosis?

• Tuberculosis in Canada, 2016
• Tuberculosis in Canada: 2016 Supplementary Tables
• Addressing tuberculosis among Inuit in Canada, 2010-2015
• A cluster of tuberculosis cases linked to smoking: An under-recognized challenge for tuberculosis elimination
• Summary of the NACI Update on Immunization in Pregnancy with Tetanus Toxoid, Reduced Diphtheria Toxoid and Reduced Acellular Pertussis (Tdap) Vaccine
• Rapid testing for TB drug-susceptibility
• Rapid diagnostic testing for TB meningitis
• Can Commun Dis Rep. 2018;44(2)
• Can Commun Dis Rep 2017;43(12)
• Can Commun Dis Rep 2017;43(11)
• Can Commun Dis Rep 2017;43(3/4)

CCDR: Volume 44-2, February 1, 2018: Sexually transmitted infections

• Gonorrhea in Canada, 2010–2015
• Infectious and congenital syphilis in Canada, 2010–2015
• Chlamydia in Canada, 2010–2015
• Lymphogranuloma venereum in Quebec: Re-emergence among men who have sex with men
• Resources to address stigma related to sexuality, substance use and sexually transmitted and blood-borne infections
• Rolling out HIV antiretroviral therapy in sub-Saharan Africa: 2003–2017
• Outbreak of Seoul virus among rats and rat owners — United States and Canada, 2017

CCDR: Volume 44-1, January 4, 2018: Emergency planning

• Federal, provincial and territorial public health response plan for biological events
• Canadian Pandemic Influenza Preparedness: Health sector planning guidance
• Canada's Pandemic Influenza Preparedness: Laboratory strategy
• Canada's Pandemic Influenza Preparedness: Surveillance strategy
• Travel-related Zika virus cases in Canada: October 2015–June 2017
• Zika virus: Where to from here?
• Canadian recommendations for laboratory interpretation of multiple or extensive drug resistance in clinical isolates of Enterobacteriaceae, Acinetobacter species and Pseudomonas aeruginosa
• Human cases of West Nile virus in Canada, 2017
• Thank you to 2017 peer reviewers